Table 1.

Patients' characteristics

Patients, N (%)
Age, yMean (range)56 (20–77)
GenderMales101 (50%)
Females100 (50%)
Histological typeThoracic35 (17%)
Colorectal33 (16%)
Breast20 (10%)
Mesothelioma17 (8%)
Genitourinary (renal, bladder, and prostate)14 (7%)
Melanoma10 (5%)
Noncolorectal GI (upper-GI, pancreas)17 (8%)
Head-and-neck cancer8 (4%)
Sarcoma8 (4%)
Gynecologic (ovarian, endometrial, and cervix)10 (5%)
Other (thyroid, carcinoma of unknown origin, adrenocortical carcinoma, etc.)29 (14%)
Previous lines of chemotherapy (N)021 (10%)
122 (11%)
243 (21%)
348 (24%)
4–867 (33%)
Number of metastatic sites (N)0–151 (25%)
287 (43%)
352 (26%)
>411 (5%)
RMH prognostic score040 (21%)
183 (44%)
251 (27%)
314 (7%)

Abbreviation: RMH, Royal Marsden Hospital.